News

Golub Capital BDC, Inc. Announces Q1 FY 2025 Earnings Call Date

Golub Capital BDC, Inc. Announces Q1 FY 2025 Earnings Call Date

Golub Capital BDC, Inc. Schedules Release of Financial Results

Golub Capital BDC, Inc., a prominent business development company known by its stock ticker NASDAQ: GBDC, has made an important announcement regarding its financial reporting. The company has confirmed that it will be releasing its financial results for the first quarter of fiscal year 2025, which ended on December 31, 2024. This revelation marks a significant event for investors and stakeholders, particularly as it highlights Golub Capital's transparent communication regarding its financial health.

Details of the Earnings Call

The earnings results will be disclosed on February 4, 2025, after the financial markets close. This strategic timing serves to provide investors and analysts alike the opportunity to carefully review the findings before the scheduled earnings conference call set for the following day.

Conference Call Participation

On February 5, 2025, at 10:00 a.m. Eastern Time, Golub Capital will hold an earnings conference call to go over the quarterly financial results in detail. Participants who are interested in joining the call should dial (888) 330-3529 about 10 to 15 minutes prior to the start time. For those calling from outside the U.S., the number to reach is (646) 960-0656. To ensure a smooth experience, participants are encouraged to reference Golub Capital BDC, Inc. when prompted.

Accessibility of Archived Calls

For individuals unable to join the live event, a replay of the conference call will be accessible shortly after the conclusion of the event. This replay will remain available until 11:59 p.m. Eastern Time on February 12, 2025. To access the replay, callers should dial (800) 770-2030 for domestic ears, while international participants can access the replay by calling (609) 800-9909. When engaging with the archived options, callers should reference program ID number 5111111.

About Golub Capital BDC, Inc.

Golub Capital BDC, Inc. operates as a non-diversified, externally-managed closed-end investment company that has chosen to be recognized as a business development company under the Investment Company Act of 1940. The firm primarily invests in senior secured loans and one-stop financing for middle-market companies, predominantly those with backing from private equity sponsors. The investment activities of GBDC are overseen by GC Advisors LLC, an affiliate of the Golub Capital group.

The Role of Golub Capital in Private Credit Management

Golub Capital is recognized as a leader in the market for private credit management, being an award-winning direct lender that emphasizes delivering innovative financing solutions to companies supported by private equity firms. This commitment to supporting businesses enhances their financial stability and growth potential.

The Financial Infrastructure

As of October 1, 2024, Golub Capital boasts over 1,000 dedicated employees and manages a capital pool exceeding $70 billion. This impressive figure reflects their gross invested capital, which includes leveraging strategies. Golub Capital operates from various locations across North America, Europe, and Asia, showcasing its global reach and influence.

Current Market Position and Future Outlook

The company's strategic focus on engaging with private equity sponsors allows it to form long-lasting partnerships, ultimately leading to repeat business and a robust investment portfolio. Golub Capital's commitment to excellence and innovation continues to position it favorably in the competitive landscape of investment management.

Frequently Asked Questions

What are the key dates for Golub Capital BDC’s upcoming earnings report?

Golub Capital will release its financial results on February 4, 2025, and will hold an earnings call the following day, February 5, 2025.

How can participants access the earnings conference call?

Participants can join the call by dialing (888) 330-3529 or (646) 960-0656 for international callers.

Is there a way to listen to the call later?

Yes, an archived replay of the call will be available until 11:59 p.m. on February 12, 2025.

What is Golub Capital BDC, Inc. known for?

Golub Capital is known for its role as a leading business development company that invests primarily in senior secured loans to middle-market companies.

How much capital does Golub Capital manage?

As of October 2024, Golub Capital manages over $70 billion in capital.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading